封面
市場調查報告書
商品編碼
1461278

週邊血管器械市場,依產品類型、最終用戶、地理位置

Peripheral Vascular Devices Market, By Product Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 185 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2024年全球週邊血管器械市值為126.8億美元,預計2031年將達到194.5億美元,2024年至2031年年複合成長率(CAGR)為6.3%。

報告範圍 報告詳情
基準年: 2023年 2023/2024 年市場規模: 126.8 億美元
歷史數據: 2019年至2023年 預測期: 2024年至2031年
預測期間 2023/2024 至 2030/2031 年複合成長率: 6.30% 2030/2031 價值預測: 194.5 億美元
週邊血管器械市場佔有率 (%)(依地區),2024 年
週邊血管器械市場 - IMG1

由於老年人口的增加和生活方式疾病的流行,全球週邊血管器械市場在過去幾年中一直穩定成長。週邊血管裝置主要用於診斷和治療週邊動脈疾病(PAD),這種疾病的特徵是動脈狹窄,減少流向四肢的血流。專注於藥物洗脫支架和評分球囊導管等先進技術開發的研究活動不斷增加,預計將對預測期內的市場擴張產生積極影響。已開發經濟體有利的報銷情況以及對早期診斷的認知不斷增強正在補充市場的成長。然而,高昂的治療成本以及一定的程序和嚴格的法規核准是阻礙市場成長的一些主要因素。

市場動態:

全球週邊血管器械市場的成長主要受到以下因素的推動:易患慢性病的老年人口不斷增加,糖尿病、肥胖等生活方式疾病的患病率不斷上升,導致外周動脈疾病,以及不斷增加的創新器械開發研究舉措。糖尿病患者感染 PAD 的高風險增加了對有效診斷和介入手術的需求,從而刺激了對週邊血管裝置的需求。然而,技術先進的設備和治療程序的高成本以及新產品核准的嚴格監管政策是限制市場成長的主要課題。同時,主要參與者正在進行的引入生物可吸收支架和高效藥物輸送系統的研發活動在預測期內為市場參與者提供了利潤豐厚的機會。

研究的主要特點:

  • 該報告對全球週邊血管器械市場進行了深入分析,並提供了以2023年為基準年的預測期(2024-2031年)的市場規模(十億美元)和年複合成長率(CAGR%)。
  • 它闡明了不同區隔市場的潛在收入機會,並解釋了該市場有吸引力的投資主張矩陣。
  • 這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
  • 它根據以下參數描述了全球週邊血管器械市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
  • 該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球週邊血管器械市場報告迎合了該行業的各個利益相關者,包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
  • 利害關係人可以透過用於分析全球週邊血管器械市場的各種策略矩陣輕鬆做出決策。

目錄

第1章:研究目標與假設

  • 研究目標
  • 假設
  • 縮寫

第 2 章:市場範圍

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map (COM)

第 3 章:市場動態、法規與趨勢分析

  • 市場動態
    • 促進要素
    • 限制
    • 市場機會
  • 影響分析
  • 市場走向
  • 最近的發展
  • 收購和合作場景
  • 技術概覽
  • 監管場景
  • PEST分析

第 4 章:全球週邊血管器材市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 整體影響
  • 對供需的影響
  • COVID-19 對市場的影響

第 5 章:全球週邊血管器材市場,依產品類型,2019 - 2031 年(十億美元)

  • 概述
  • 週邊血管支架
  • 週邊腔內血管成形術球囊導管
  • PTA導絲
  • 斑塊切除裝置
  • 慢性完全閉塞裝置
  • 主動脈支架
  • 合成手術移植物
  • 其他

第 6 章:全球週邊血管器械市場,依最終用戶分類,2019 - 2031 年(十億美元)

  • 概述
  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他

第 7 章:2019 - 2031 年全球週邊血管器材市場(依地區)(十億美元)

  • 介紹
  • 北美洲
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 東協
  • 澳洲
  • 韓國
  • 亞太地區其他地區
  • 中東
  • 海灣合作理事會
  • 以色列
  • 中東其他地區
  • 非洲
  • 北非
  • 中非
  • 南非

第 8 章:競爭格局

  • Abbot Laboratories
  • Boston Scientific Corporation
  • Angioscore
  • Emboline Inc.
  • Becton Dickinson, and Company
  • Cook Group Inc.
  • Cordis Corporation
  • Covidien PLC
  • Edward Lifesciences Corporation
  • Medtronic Plc
  • St. Jude Medical
  • Bayer AG
  • Teleflex Medical
  • Koninklijke Philips N.V.
  • Cardio Flow, Inc.

第 9 章:分析師觀點

  • 命運之輪
  • 分析師觀點
  • 連貫的機會圖

第 10 章:參考文獻與研究方法

  • 參考
  • 研究方法論
簡介目錄
Product Code: CMI391

Global peripheral vascular devices market is estimated to be valued at USD 12.68 Bn in 2024 and is expected to reach USD 19.45 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.3% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 12.68 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 6.30% 2030/2031 Value Projection: US$ 19.45 Bn
Peripheral Vascular Devices Market Share (%), By Region, 2024
Peripheral Vascular Devices Market - IMG1

Global peripheral vascular devices market has been witnessing steady growth over the past few years owing to increasing geriatric population and prevalence of lifestyle diseases. Peripheral vascular devices are majorly used in diagnosis and treatment of peripheral artery disease (PAD), a condition characterized by narrowed arteries reducing blood flow to limbs. Rising research activities focusing on development of advanced technologies such as drug-eluting stents and scoring balloon catheters is expected to positively influence the market expansion during the forecast period. Favorable reimbursement scenario in developed economies and growing awareness regarding early diagnosis are supplementing the market growth. However, high cost of treatment accompanied with certain procedures and strict regulatory approvals are some of the major factors impeding the market growth.

Market Dynamics:

Global peripheral vascular devices market growth is primarily driven by increasing geriatric population prone to chronic diseases, growing prevalence of lifestyle diseases such as diabetes, obesity leading to peripheral artery disease as well as rising research initiatives for development of innovative devices. High risk of contracting PAD in diabetic patients boosts the need for effective diagnostic and interventional procedures, thereby, fueling demand for peripheral vascular devices. However, high cost of technologically advanced devices and treatment procedures along with stringent regulatory policies for new product approvals are major challenges restraining the market growth. Meanwhile, ongoing research & development activities embarked by key players to introduce bio-absorbable stents and efficient drug delivery systems present lucrative opportunities for market players over the forecast period.

Key Features of the Study:

  • This report provides in-depth analysis of the global peripheral vascular devices market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global peripheral vascular devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Abbott Laboratories, Boston Scientific Corporation, Angioscore, Emboline Inc., Becton Dickinson and Company, Cook Group Inc., Cordis Corporation, Covidien PLC, Edward Lifesciences Corporation, Medtronic Plc, St. Jude Medical, Bayer AG, Teleflex Medical, Koninklijke Philips N.V., and Cardio Flow, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global peripheral vascular devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peripheral vascular devices market.

Detailed Segmentation-

  • Product Type:
    • Peripheral Vascular Stents
    • Peripheral Transluminal Angioplasty Balloon Catheters
    • PTA Guidewires
    • Atherectomy Devices
    • Chronic Total Occlusion Devices
    • Aortic Stents
    • Synthetic Surgical Grafts
    • Others
  • End User:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Angioscore
    • Emboline Inc.
    • Becton Dickinson and Company
    • Cook Group Inc.
    • Cordis Corporation
    • Covidien PLC
    • Edward Lifesciences Corporation
    • Medtronic Plc
    • Jude Medical
    • Bayer AG.
    • Teleflex Medical
    • Koninklijke Philips N.V.
    • Cardio Flow, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Overview
  • Regulatory Scenario
  • PEST Analysis

4. Global Peripheral Vascular Devices Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Impact on Supply and Demand
  • COVID-19 Impact on the market

5. Global Peripheral Vascular Devices Market, By Product Type, 2019 - 2031, (USD BN)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Peripheral Vascular Stents
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Peripheral Transluminal Angioplasty Balloon Catheters
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • PTA Guidewires
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Atherectomy Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Chronic Total Occlusion Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Aortic Stents
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Synthetic Surgical Grafts
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

6. Global Peripheral Vascular Devices Market, By End User, 2019 - 2031, (USD BN)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Specialty Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

7. Global Peripheral Vascular Devices Market, By Region, 2019 - 2031, (USD BN)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD BN)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

  • Abbot Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Angioscore
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Emboline Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Becton Dickinson, and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cook Group Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cordis Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Covidien PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Edward Lifesciences Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medtronic Plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • St. Jude Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Teleflex Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Koninklijke Philips N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cardio Flow, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact